Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype

This publication has 16 references indexed in Scilit:

• The role of chemotherapy in the management of nasopharyngeal carcinoma
  Cancer, 1998
• UCNT: Chemocurable sometimes, but not very often
  Published by Elsevier ,1997
• Chemotherapy with Cisplatin and Continuous Infusion of 5-Fluorouracil and Bleomycin for Recurrent and Metastatic Nasopharyngeal Carcinoma in Taiwan
  Oncology, 1993
• Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
  European Journal Of Cancer, 1992
• Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the princess margaret hospital experience
  Cancer, 1991
• Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
  Journal of Clinical Oncology, 1991
• Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region
  Cancer, 1990
• Distant metastases of nasopharyngeal carcinoma: A study of 256 male patients
  Journal of Surgical Oncology, 1986
• Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck
  European Journal of Cancer and Clinical Oncology, 1986
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958